These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 1638522

  • 1. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ, Nelson K, Srinivasan S, Powell DE, Kenady DE, DePriest PD, Gallion HH, van Nagell JR.
    Cancer Res; 1992 Aug 01; 52(15):4106-12. PubMed ID: 1638522
    [Abstract] [Full Text] [Related]

  • 2. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 01; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 3. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
    Winneker RC, Clark JH.
    Endocrinology; 1983 Jun 01; 112(6):1910-5. PubMed ID: 6682755
    [Abstract] [Full Text] [Related]

  • 4. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Treat Rep; 1976 Oct 01; 60(10):1421-9. PubMed ID: 1035504
    [Abstract] [Full Text] [Related]

  • 5. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS, Miller MA, Eckert RL, Sudo K.
    J Steroid Biochem; 1983 Jul 01; 19(1A):59-68. PubMed ID: 6887873
    [Abstract] [Full Text] [Related]

  • 6. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK, Sutherland RL.
    Mol Pharmacol; 1987 May 01; 31(5):541-51. PubMed ID: 3553893
    [Abstract] [Full Text] [Related]

  • 7. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun 01; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 8. Biological activity and receptor binding of a strongly interacting estrogen in human breast cancer cells.
    Reiner GC, Katzenellenbogen BS, Bindal RD, Katzenellenbogen JA.
    Cancer Res; 1984 Jun 01; 44(6):2302-8. PubMed ID: 6547074
    [Abstract] [Full Text] [Related]

  • 9. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
    Sheen YY, Simpson DM, Katzenellenbogen BS.
    Endocrinology; 1985 Aug 01; 117(2):561-4. PubMed ID: 4017947
    [Abstract] [Full Text] [Related]

  • 10. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep 01; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar 01; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 12. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ, Froese EK.
    Cancer Res; 1982 Dec 01; 42(12):5147-51. PubMed ID: 7139616
    [Abstract] [Full Text] [Related]

  • 13. Comparison of estrogen receptor DNA binding in untreated and acquired antiestrogen-resistant human breast tumors.
    Johnston SR, Lu B, Dowsett M, Liang X, Kaufmann M, Scott GK, Osborne CK, Benz CC.
    Cancer Res; 1997 Sep 01; 57(17):3723-7. PubMed ID: 9288779
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol.
    Sato T, Ohta Y, Okamura H, Hayashi S, Iguchi T.
    Anat Rec; 1996 Mar 01; 244(3):374-85. PubMed ID: 8742702
    [Abstract] [Full Text] [Related]

  • 15. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK, Ruh MF, Butler WB, Ruh TS.
    Endocrinology; 1986 Mar 01; 118(3):1087-95. PubMed ID: 3948766
    [Abstract] [Full Text] [Related]

  • 16. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
    Burke PJ, Kalet BT, Koch TH.
    J Med Chem; 2004 Dec 16; 47(26):6509-18. PubMed ID: 15588086
    [Abstract] [Full Text] [Related]

  • 17. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
    Clarke R, Liu MC, Bouker KB, Gu Z, Lee RY, Zhu Y, Skaar TC, Gomez B, O'Brien K, Wang Y, Hilakivi-Clarke LA.
    Oncogene; 2003 Oct 20; 22(47):7316-39. PubMed ID: 14576841
    [Abstract] [Full Text] [Related]

  • 18. Characterization of high specific activity [16 alpha-123I]Iodo-17 beta-estradiol as an estrogen receptor-specific radioligand capable of imaging estrogen receptor-positive tumors.
    Pavlik EJ, Nelson K, Gallion HH, van Nagell JR, Donaldson ES, Shih WJ, Spicer JA, Preston DF, Baranczuk RJ, Kenady DE.
    Cancer Res; 1990 Dec 15; 50(24):7799-805. PubMed ID: 2253222
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of estrogen receptor, antiestrogen binding sites and calmodulin for antiestrogen resistance of two clones derived from the MCF-7 breast cancer cell line.
    Borras M, Jin L, Bouhoute A, Legros N, Leclercq G.
    Biochem Pharmacol; 1994 Nov 29; 48(11):2015-24. PubMed ID: 7802690
    [Abstract] [Full Text] [Related]

  • 20. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS, Baudendistel LJ.
    Endocrinology; 1977 Feb 29; 100(2):420-6. PubMed ID: 832632
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.